1. IndiaInfoline
  2. Search
Displaying Results for "lupin"
Showing Results 1 - 19 of 1628

Lupin allots equity shares

capital market  | Mumbai January 19, 2015 11:48 IST

Under ESOP

Lupin to hold board meeting

capital market  | Mumbai January 15, 2015 12:27 IST

On 3 February 2015

Lupin expects 8-10 product launches in US in second half: Kamal Sharma

India Infoline News Service  | Mumbai January 12, 2015 17:00 IST

The stock of the company closed up 0.83% at Rs. 1431.40. It hit a high at Rs. 1434.30 and low at Rs. 1416.50.

Lupin launches Generic DIOVAN Tablets

capital market  | Mumbai January 06, 2015 15:46 IST

On receiving USFDA approval

Lupin stock trades flat

India Infoline News Service  | Mumbai December 31, 2014 11:46 IST

The stock has hit a high of Rs. 1,442 and a low of Rs. 1,423.

Lupin gains on receiving tentative approval from USFDA to market generic Prezista tablets

capital market  | Mumbai December 31, 2014 09:30 IST

Lupin rose 0.79% to Rs 1,440 at 9:32 IST on BSE after company said that it has received tentative approval from USFDA to market its Darunavir Ethanolate Tablets, a generic version of Janssen Products, LP (Janssen) Prezista.

Lupin may gain on receiving tentative approval for its Darunavir Ethanolate Tablets from USFDA

capital market  | Mumbai December 31, 2014 08:45 IST

Lupin may gain on receiving tentative approval for its Darunavir Ethanolate Tablets from USFDA

Lupin receives Tentative approval for Generic Prezista Tablets

India Infoline News Service  | Mumbai December 30, 2014 17:12 IST

Shares of Lupin stock ended flat at Rs. 1,428.70.

Lupin receives tentative approval for generic Prezista Tablets

capital market  | Mumbai December 30, 2014 16:21 IST

From USFDA

Lupin receives tentative approval for generic Prezista Tablets

capital market  | Mumbai December 30, 2014 00:00 IST

Lupin announced that it has received tentative approval for its Darunavir Ethanolate Tablets 75 mg, 150 mg, 300 mg, 400mg, 600 mg and 800 mg from the United State Food & Drug Adminstration (FDA) to market a generic version of Janssen Products, LP (Janssen) Prezista Tablets 75 mg, 150 mg, 300 mg, 400mg, 600 mg.

Lupin explores opportunities for organic and inorganic growth

India Infoline News Service  | Mumbai December 29, 2014 15:03 IST

The Exchange had sought clarification from Lupin with respect to news article appearing in Financial Chronicle on December 29, 2014 titled "Lupin acquisitions to bolster global presence"

Lupin in the pink of health

capital market  | Mumbai December 29, 2014 12:57 IST

Lupin rose 1.28% to Rs 1,424.45 at 13:02 IST on BSE on buzz that the company is eyeing acquisitions in global market in US, Latin America and Europe.

Seeking new markets! Lupin eyes acquisitions

India Infoline News Service  | Mumbai December 29, 2014 11:38 IST

Swaminathan said the company has signed various agreements in the US market in FY 14, including the one inked with Romark Laboratories.

Lupin receives FDA Approval for Generic Epivir Tablets

capital market  | Mumbai December 26, 2014 14:55 IST

Lupin Pharmaceutical Inc. to market Lamivudine Tablets 150 mg and 300 mg

Lupin receives FDA Approval for Generic Epivir Tablets

India Infoline News Service  | Mumbai December 26, 2014 14:47 IST

At 2.47 PM, the stock was up 0.44% at Rs. 1,408.95. The stock has hit a high of Rs. 1,416.05 and a low of Rs. 1,392.

Lupin receives FDA Approval for Generic Epivir Tablets

capital market  | Mumbai December 26, 2014 00:00 IST

Lupin announced that it has received final approval for its Lamivudine Tablets 150 mg and 300 mg from the United State Food & Drug Administration (USFDA) to market generic version of ViiV Healthcare's Epivir Tablets 150 mg and 300 mg. Lupin Pharmaceutical Inc., the Company's US subsidiary would commence marketing the product shortly.

Lupin explores opportunities for organic and inorganic growth

India Infoline News Service  | Mumbai December 18, 2014 12:44 IST

Earlier Exchange has sought clarification from Lupin Ltd with respect to news article appearing in Economic Times on December 15, 2014 titled "Scouting for Acquisitions"

Lupin allots equity shares

capital market  | Mumbai December 17, 2014 17:24 IST

Of Rs 2 each

Lupin allots equity shares

capital market  | Mumbai December 17, 2014 00:00 IST

Lupin announced that its committee of directors in the meeting held on 17 December 2014 allotted 104047 fully paid up equity shares of Rs 2 each upon exercising of options granted to its employees under the stock option plans of the company. Post allotment , the paid up capital of the company has increased to Rs 89.84 lakhs consisting 44.92 lakhs equity shares of Rs 2 each.

Back to Top

 
 
Reports

Another day, another high

India Infoline News Service / 09:04, Jan 22, 2015

The outlook is a flat start. The market will look to scale to new peaks though not much effort is needed for the same. HUL saw a rally and short-covering may have pulled it up further. Speculation is on that its parent will raise stake through an open offer. After the cooling in oil prices, Cairn results will be in focus.

News